211 related articles for article (PubMed ID: 14692962)
1. Reduction of febrile but not allergic reactions to RBCs and platelets after conversion to universal prestorage leukoreduction.
Paglino JC; Pomper GJ; Fisch GS; Champion MH; Snyder EL
Transfusion; 2004 Jan; 44(1):16-24. PubMed ID: 14692962
[TBL] [Abstract][Full Text] [Related]
2. Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs.
King KE; Shirey RS; Thoman SK; Bensen-Kennedy D; Tanz WS; Ness PM
Transfusion; 2004 Jan; 44(1):25-9. PubMed ID: 14692963
[TBL] [Abstract][Full Text] [Related]
3. The effect of prestorage WBC reduction on the rates of febrile nonhemolytic transfusion reactions to platelet concentrates and RBC.
Yazer MH; Podlosky L; Clarke G; Nahirniak SM
Transfusion; 2004 Jan; 44(1):10-5. PubMed ID: 14692961
[TBL] [Abstract][Full Text] [Related]
4. Prestorage universal WBC reduction of RBC units does not affect the incidence of transfusion reactions.
Uhlmann EJ; Isgriggs E; Wallhermfechtel M; Goodnough LT
Transfusion; 2001 Aug; 41(8):997-1000. PubMed ID: 11493730
[TBL] [Abstract][Full Text] [Related]
5. Effects of Prestorage Leukoreduction on the Rate of Febrile Nonhemolytic Transfusion Reactions to Red Blood Cells in a Tertiary Care Hospital.
Rajesh K; Harsh S; Amarjit K
Ann Med Health Sci Res; 2015; 5(3):185-8. PubMed ID: 26097760
[TBL] [Abstract][Full Text] [Related]
6. Effects of prestorage vs poststorage leukoreduction on the rate of febrile nonhemolytic transfusion reactions to platelets.
Wang RR; Triulzi DJ; Qu L
Am J Clin Pathol; 2012 Aug; 138(2):255-9. PubMed ID: 22904138
[TBL] [Abstract][Full Text] [Related]
7. Universal leukodepletion of blood components results in a significant reduction of febrile non-hemolytic but not allergic transfusion reactions.
Pruss A; Kalus U; Radtke H; Koscielny J; Baumann-Baretti B; Balzer D; Dörner T; Salama A; Kiesewetter H
Transfus Apher Sci; 2004 Feb; 30(1):41-6. PubMed ID: 14746820
[TBL] [Abstract][Full Text] [Related]
8. The influence of leukoreduction on the acute transfusion-related complication rate in 455 dogs receiving 730 packed RBCs: 2014-2017.
Davidow EB; Montgomery H; Mensing M
J Vet Emerg Crit Care (San Antonio); 2022 Jul; 32(4):479-490. PubMed ID: 35043550
[TBL] [Abstract][Full Text] [Related]
9. Incidence of transfusion-related adverse reactions per patient reflects the potential risk of transfusion therapy in Japan.
Kato H; Uruma M; Okuyama Y; Fujita H; Handa M; Tomiyama Y; Shimodaira S; Kurata Y; Takamoto S
Am J Clin Pathol; 2013 Aug; 140(2):219-24. PubMed ID: 23897258
[TBL] [Abstract][Full Text] [Related]
10. The utility of < or =3-day-old whole-blood platelets in reducing the incidence of febrile nonhemolytic transfusion reactions.
Kelley DL; Mangini J; Lopez-Plaza I; Triulzi DJ
Transfusion; 2000 Apr; 40(4):439-42. PubMed ID: 10773056
[TBL] [Abstract][Full Text] [Related]
11. Platelet transfusions in children: results of a randomized, prospective, crossover trial of plasma removal and a prospective audit of WBC reduction.
Couban S; Carruthers J; Andreou P; Klama LN; Barr R; Kelton JG; Heddle NM
Transfusion; 2002 Jun; 42(6):753-8. PubMed ID: 12147029
[TBL] [Abstract][Full Text] [Related]
12. [The effect of leukocyte-reduction on the transfusion reactions to red blood cells concentrates].
Mukagatare I; Monfort M; de Marchin J; Gerard C
Transfus Clin Biol; 2010 Feb; 17(1):14-9. PubMed ID: 20106700
[TBL] [Abstract][Full Text] [Related]
13. [Introduction of platelet additive solution in platelet concentrates: towards a decrease of blood transfusion reactions].
Rebibo D; Simonet M; Hauser L
Transfus Clin Biol; 2008 Nov; 15(5):289-93. PubMed ID: 18930424
[TBL] [Abstract][Full Text] [Related]
14. Febrile and allergic transfusion reactions after the transfusion of white cell-poor platelet preparations.
Klüter H; Bubel S; Kirchner H; Wilhelm D
Transfusion; 1999; 39(11-12):1179-84. PubMed ID: 10604243
[TBL] [Abstract][Full Text] [Related]
15. Hypotensive transfusion reactions in the era of prestorage leukoreduction.
Pagano MB; Ness PM; Chajewski OS; King KE; Wu Y; Tobian AA
Transfusion; 2015 Jul; 55(7):1668-74. PubMed ID: 25731668
[TBL] [Abstract][Full Text] [Related]
16. Febrile transfusion reaction: what blood component should be given next?
Menitove JE; McElligott MC; Aster RH
Vox Sang; 1982; 42(6):318-21. PubMed ID: 7113112
[TBL] [Abstract][Full Text] [Related]
17. Decrease in the Risk of Posttransplant Hepatocellular Carcinoma Recurrence After the Conversion to Prestorage Leukoreduction for Transfused Red Blood Cells.
Kwon JH; Han S; Jang JS; Lee KW; Ahn JH; Kim K; Jeon S; Gwak MS; Ko JS; Kim GS; Joh JW; Cho D
Transplantation; 2021 Mar; 105(3):577-585. PubMed ID: 32265418
[TBL] [Abstract][Full Text] [Related]
18. Effect of premedication guidelines and leukoreduction on the rate of febrile nonhaemolytic platelet transfusion reactions.
Patterson BJ; Freedman J; Blanchette V; Sher G; Pinkerton P; Hannach B; Meharchand J; Lau W; Boyce N; Pinchefsky E; Tasev T; Pinchefsky J; Poon S; Shulman L; MacK P; Thomas K; Blanchette N; Greenspan D; Panzarella T
Transfus Med; 2000 Sep; 10(3):199-206. PubMed ID: 10972914
[TBL] [Abstract][Full Text] [Related]
19. Pre-storage leucocyte depletion and transfusion reaction rates in cancer patients.
Da Ponte A; Bidoli E; Talamini R; Steffan A; Abbruzzese L; Toffola RT; De Marco L
Transfus Med; 2005 Feb; 15(1):37-43. PubMed ID: 15713127
[TBL] [Abstract][Full Text] [Related]
20. A randomized controlled trial comparing the frequency of acute reactions to plasma-removed platelets and prestorage WBC-reduced platelets.
Heddle NM; Blajchman MA; Meyer RM; Lipton JH; Walker IR; Sher GD; Constantini LA; Patterson B; Roberts RS; Thorpe KE; Levine MN
Transfusion; 2002 May; 42(5):556-66. PubMed ID: 12084163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
